Impact Award - Chordoma Foundation
Impact Award - Chordoma Foundation supports researchers pursuing preclinical and translational chordoma immunology studies to accelerate research into innovative immunotherapy approaches.
Browse similar grants
Funder: Chordoma Foundation
Due Dates: December 1, 2026 (Initial application)
Funding Amounts: $300,000 USD over two years
Summary: Supports preclinical and translational chordoma immunology research exploring innovative immunotherapy approaches.
Description
The Chordoma Foundation offers the Impact Award through its ongoing collaboration with the Cancer Research Institute (CRI). Now in its eighth consecutive year, the partnership supports chordoma-focused immunology research, with an emphasis on preclinical and translational studies exploring new immunotherapy approaches. The award aims to accelerate innovative immunotherapy research in chordoma, a rare bone cancer of the skull base and spine.
The opportunity is part of the Foundation’s broader commitment to high-impact chordoma research addressing priorities defined by its medical and scientific advisors. Those broader priorities include target discovery, predictive biomarkers, mechanisms of immune evasion, and Brachyury (TBXT) drug discovery. They provide context for the Foundation’s research strategy rather than separate requirements for this award.
